Pharmafile Logo
Pharmafocus logo
Advanced Search

COPD

Showing 15 posts of 79 posts found.

GSK image

GSK double complaint ruled out by PMCPA

January 16, 2015
Medical Communications, Sales and Marketing ABPI, COPD, GSK, PMCPA, Relvar, Seretide

Complaints questioning the promotion of two of GlaxoSmithKline’s chronic obstructive pulmonary disease (COPD) drugs have been ruled out by a …

News
Strivrerdi image

Boehringer complaint ruled out by PMCPA

January 15, 2015
Medical Communications, Sales and Marketing ABPI, Boehringer, COPD, PMCPA, Striverdi, olodaterol

A complaint made by a pharmacist stating that the artwork image for Boehringer Ingelheim’s COPD drug Striverdi is misleading has …

News
Janssen image

Vectura and J&J shake on asthma/COPD deal

January 6, 2015
Research and Development, Sales and Marketing COPD, J&J, JJ, Janssen, asthma, johnson, rezolsta, tybost, vectura

British firm Vectura has entered an agreement with Johnson & Johnson’s pharma unit Janssen to develop therapies for asthma and …

News
Advair image

Europe must prepare for COPD ‘timebomb’

November 19, 2014
Sales and Marketing COPD, Europe, European COPD Coalition, Spiriva, asthma, chronic obstructive pulmonary disease

Health services in Europe are not making sufficient effort to cope with the escalating burden of chronic obstructive pulmonary disease …

News

Gamification: what’s in it for the pharma industry?

October 6, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AF, Boehringer, COPD, CRUK, Gamification, ROI, Syrum, digital

Gamification is the new buzzword in digital marketing and has the potential to engage consumers more than traditional strategies. This …

Feature
boehringer_angle_22

Boehringer’s Striverdi gains FDA approval

August 1, 2014
Sales and Marketing Advair, COPD, Pfizer, Spiriva, asthma, olodaterol

Boehringer Ingelheim’s new lung drug Striverdi has gained US approval for patients with chronic obstructive pulmonary disorder. Striverdi Respimat (olodaterol), …

News
Astrazeneca image

AstraZeneca signs $240m asthma deal with UK biotech

June 12, 2014
Sales and Marketing AZ, AstraZeneca, COPD, SNG001, Synairgen

UK-based Synairgen has signed a global licence agreement with fellow British native AstraZeneca for its experimental lung drug SNG001. The …

News

Europe poised for generic Symbicort

February 24, 2014
Manufacturing and Production, Sales and Marketing AstraZeneca, CHMP, COPD, Symbicort, Teva, breo, generics

The CHMP has given Teva Pharmaceutical Industries a lift by recommending that its generic version of AstraZeneca’s lung drug Symbicort …

News
GSK image

CHMP breathes new life into GSK, Teva and Novartis

February 24, 2014
Research and Development, Sales and Marketing CHMP, COPD, EMA, GSK, Gilead, Teva, asthma, onoro

The CHMP has given its backing to a number of new treatments for respiratory diseases, which include two from London-based …

News
gsk image

GSK/Theravance lung drug bags CHMP approval

February 21, 2014
Sales and Marketing CHMP, COPD, GSK, Theravance, anoro

The CHMP has given its backing to GlaxoSmithKline and partner Theravance’s new chronic obstructive pulmonary disease medicine Anoro. The treatment …

News

GSK banks on bioelectronics with new fund

August 9, 2013
Medical Communications, Research and Development, Sales and Marketing Bioelectronics, COPD, GSK, asthma, diabetes

GSK has established a $50 million venture capital fund to invest in the emerging field of bioelectronics. Described as one …

News
astrazeneca image

AstraZeneca to pay up to $1.2 billion for Pearl

June 10, 2013
Research and Development, Sales and Marketing AstraZeneca, COPD, pearl therapeutics

AstraZeneca is betting big on lung disease specialist Pearl Therapeutics as it looks to spend $1.2 billion to acquire the …

News
GSK image

GSK submits UMEC monotherapy

April 29, 2013
Sales and Marketing COPD, EMA, GSK, UMEC

GlaxoSmithKline has put its investigational once-daily medicine umeclidinium bromide (UMEC) up for scrutiny by European regulators for patients with chronic …

News
roche image

Roche bins Galapagos tie-up

March 12, 2013
Sales and Marketing COPD, Galapagos, Roche

Roche has ended its three-year old alliance with Belgian drug discovery specialist Galapagos because of a ‘strategic change’. The companies …

News
Astrazeneca image

AstraZeneca signs respiratory deal

January 29, 2013
Research and Development, Sales and Marketing AstraZeneca, COPD, orexo, respiratory

AstraZeneca has signed a research deal with Swedish pharma company Orexo centred around the development of respiratory disease treatments. For …

News

Latest content

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023

ONK Therapeutics and NAYA Biosciences enter partnership for NK cell therapy development

December 7, 2023

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023